Evidence map›Paper›PMID 31634227›Full record

ArticleCornea2020

Association Between Early Sjögren Markers and Symptoms and Signs of Dry Eye.

Sasha Hubschman, Mario Rojas, Meghana Kalavar, Amy Kloosterboer, Alfonso L Sabater, Anat Galor

Open access · greenAbstract read
In one paragraph

Article in Cornea, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sasha HubschmanDepartment of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Mario RojasDepartment of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Meghana KalavarDepartment of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Amy KloosterboerDepartment of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Alfonso L SabaterDepartment of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, Miami, FL.
Anat GalorDepartment of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
United States Department of Veterans Affairs · US

Funding

Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Abigail S Hackam · 2004 to 2026
$12.2M
Dry Eye and MicroenvironmentR01EY026174 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GALOR, ANAT, KUMAR, NARESH · 2016 to 2020
$1.9M
NEUROPATHIC PAIN: A CRITICAL MISSING PIECE IN DRY EYE?I01CX001089 · VA · MIAMI VA HEALTH CARE SYSTEM · PI GALOR, ANAT · 2016 to 2019
–
BLRD VA I01 BX004893CSRD VA I01 CX001089NEI NIH HHS P30 EY014801NEI NIH HHS R01 EY026174
6 · The paper itself

Abstract

purposeAnimal models suggest that early markers of Sjögren syndrome (EMS)-antibodies against salivary protein 1, parotid secretory protein, and carbonic anhydrase 6 (CA6)-are more accurate signals of early Sjögren when compared with classic markers (anti-Ro and anti-La). To further understand the relationship between EMS and dry eye (DE), we compared symptoms and signs of DE in subjects who tested positive versus negative for EMS.

methodsIn this cross-sectional study, patients at the Miami Veterans Affairs Eye Clinic who were tested for EMS underwent a standard ocular surface examination. Indications for EMS testing included DE symptoms in combination with dry mouth symptoms, low tear production, corneal staining, or a Sjögren disease-associated autoimmune disease. Statistical tests performed were the χ test, Fisher exact test, independent sample t test, and Spearman correlation.

resultsSeventy-three percent of 44 patients tested positive for 1 or more EMS. CA6 IgG was most frequently elevated, followed by CA6 IgM and parotid secretory protein IgG. EMS-positive versus EMS-negative subjects were more likely to escalate DE treatment past artificial tears to topical cyclosporine (n = 32, 100% vs. n = 9, 75%, P = 0.02). There were no demographic or comorbidity differences between EMS-positive and EMS-negative subjects, and marker levels did not correlate with more severe tear film measures.

conclusionsMost of the individuals with DE tested positive for 1 or more EMS antibodies, including men and Hispanics. Future studies will be needed to understand how to incorporate EMS data into the care of an individual with DE.

Indexed as

AdultAntibodies, AntinuclearBiomarkersCarbonic AnhydrasesCross-Sectional StudiesDry Eye SyndromesFemaleHumansMaleMiddle AgedRetrospective StudiesRibonucleoproteinsSalivary Proteins and PeptidesSjogren's SyndromeSS-A AntigenTearsAntibodies, AntinuclearBiomarkersBPIFA2 protein, humanCarbonic Anhydrasescarbonic anhydrase VIRibonucleoproteinsSalivary Proteins and PeptidesSS-A AntigenSS-B antibodies

Identifiers

PMID31634227
PMCPMC7007845
OpenAlexW2980775714

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.